Medication use evaluation: Ceftazidime-Avibactam combination therapy compared to Ceftazidime-Avibactam monotherapy

• At: Seville (Spain) (2022)
• Type: Digital
• By: CHEN, Pei-chun (Taipei City Hospital Yangming Branch, China Taiwan)
• Co-author(s): Ms Pei-chun Chen (Taipei City Hospital Yangming Branch, Taipei, China Taiwan)
  Mr. Kai-Hsiang Yang, Pharmacy (Taipei City Hospital Yangming Branch, Taipei, China Taiwan)
  
• Abstract:

  Background information: The medicinal product Ceftazidime-Avibactam (Zavicefta®) is first-line therapy for the treatment of refractory infections caused by Gram-negative bacilli.
  
  Purpose: The purpose of this study was to evaluate the efficacy and adverse effects of Ceftazidime-Avibactam combined with other antibiotics and Ceftazidime-Avibactam..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login